NCT02182557View on ClinicalTrials.gov

WAL 801 CL Dry Syrup in Paediatric Atopic Dermatitis Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

162

Participants

Timeline

Start Date

June 30, 2001

Primary Completion Date

January 31, 2002

Conditions
Dermatitis, Atopic
Interventions
DRUG

WAL 801 CL Dry Syrup

DRUG

Ketotifen Fumarate Dry Syrup

DRUG

WAL 801 CL Dry Syrup placebo

DRUG

Ketotifen Fumarate Dry Syrup placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY